← back to search

Christopher Kobylecki

Manchester Academic Health Science Centre · GB
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Genetic Neurodegenerative Diseases, and Botulinum Toxin and Related Neurological Disorders.
h-index
26
citations
2,318
works
141
NIH funding
primary concept
email

Recent publications

Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group
Communications Medicine 2025cited by 4position: middledoi
Genome sequence analyses identify novel risk loci for multiple system atrophy
Neuron 2024cited by 40position: middledoi
Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study
Alzheimer s & Dementia 2024cited by 34position: middledoi
MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
The Lancet Neurology 2024cited by 23position: middledoi
Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease
Parkinsonism & Related Disorders 2023cited by 13position: middledoi
Dissecting the Phenotype and Genotype of <scp><i>PLA2G6</i></scp>‐Related Parkinsonism
Movement Disorders 2021cited by 58position: middledoi
Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy
Neurobiology of Disease 2021cited by 28position: middledoi
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study
The Lancet Neurology 2020cited by 119position: middledoi
A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease
Parkinsonism & Related Disorders 2018cited by 129position: middledoi
Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study
Parkinsonism & Related Disorders 2015cited by 151position: middledoi
<sup>18</sup>F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease
Journal of Nuclear Medicine 2015cited by 47position: firstdoi
Lung Function Testing <i>On</i> and <i>Off</i> Dopaminergic Medication in Parkinson's Disease Patients With and Without Dysphagia
Movement Disorders Clinical Practice 2015cited by 8position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Monty Silverdale · University of Manchester3 papers (2015–2021)José Anton‐Rodriguez · University of Manchester2 papers (2015–2023)Georgios Ponirakis · Cornell University2 papers (2015–2021)Andrew Marshall · London Borough of Hackney2 papers (2015–2021)Rainer Hinz · University of London2 papers (2015–2023)Alexander Gerhard · University of Manchester2 papers (2015–2023)Rayaz A. Malik · Manchester Academic Health Science Centre2 papers (2015–2021)Lewis Kass‐Iliyya · University of Manchester2 papers (2015–2018)К. Ray Chaudhuri · UK Dementia Research Institute2 papers (2015–2018)Maryam Ferdousi · Manchester Academic Health Science Centre2 papers (2015–2021)Karl Herholz · University of Manchester2 papers (2015–2023)Zane Jaunmuktane · King's College London1 papers (2021–2021)Michael J. Pontecorvo · Eli Lilly (United States)1 papers (2015–2015)Nicholas Wood · University of Colorado Denver1 papers (2021–2021)Dorothee Kübler · Charité - Universitätsmedizin Berlin1 papers (2023–2023)Xiajun Zhou · Shanghai Jiao Tong University1 papers (2021–2021)Pablo Martínez‐Martín · University of Rochester1 papers (2018–2018)Fahd Baig · Massachusetts Institute of Technology1 papers (2018–2018)Mitra Tavakoli · MGH Institute of Health Professions1 papers (2015–2015)Emilia Michou · University of Manchester1 papers (2015–2015)